papaverine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valipour, M | 1 |
| Irannejad, H | 1 |
| Emami, S | 1 |
| Ashrafi, S | 1 |
| Alam, S | 1 |
| Sultana, A | 1 |
| Raj, A | 1 |
| Emon, NU | 1 |
| Richi, FT | 1 |
| Sharmin, T | 1 |
| Moon, M | 1 |
| Park, MN | 1 |
| Kim, B | 1 |
| Ellinger, B | 1 |
| Bojkova, D | 1 |
| Zaliani, A | 1 |
| Cinatl, J | 1 |
| Claussen, C | 1 |
| Westhaus, S | 1 |
| Keminer, O | 1 |
| Reinshagen, J | 1 |
| Kuzikov, M | 1 |
| Wolf, M | 1 |
| Geisslinger, G | 1 |
| Gribbon, P | 1 |
| Ciesek, S | 1 |
1 review available for papaverine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Papaverine: A Miraculous Alkaloid from Opium and Its Multimedicinal Application.
Topics: Alkaloids; Benzylisoquinolines; COVID-19; Humans; Opium; Papaverine; SARS-CoV-2 | 2023 |
2 other studies available for papaverine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs).
Topics: Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; | 2022 |
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection.
Topics: Antiviral Agents; Benzamidines; Caco-2 Cells; Cetylpyridinium; COVID-19; Drug Evaluation, Preclinica | 2021 |